drug-coated balloon (DCB)

BD has responded to warnings from the FDA surrounding risks from drug-coated devices by trying to reassure customers and shareholders. Read more


As a result of the outcomes of a trial comparing two drug-coated balloon (DCB) devices, in which no statistically significant patency rate difference was found, GlobalData, has indicated a potential change in the competitive landscape Read more